Rheolytic thrombectomy and platelet glycoprotein IIb/IIIa blockade for stent thrombosis
✍ Scribed by Stéphane Rinfret; Donald E. Cutlip; Peter T. Katsiyiannis; Kalon K.L. Ho; David J. Cohen; Joseph P. Carrozza Jr.; Roger J. Laham
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 460 KB
- Volume
- 57
- Category
- Article
- ISSN
- 1522-1946
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract We report on two cases of acute coronary stent thrombosis after early withdrawal of different competitive inhibitors of the platelet glycoprotein IIb/IIIa receptor, eptifibatide and tirofiban. Differences in pharmacokinetics between different types of glycoprotein IIb/IIIa receptor bloc
A 4-month-old girl with Kawasaki disease, large coronary artery aneurysms, and coronary thrombi was treated with standard therapy followed by abciximab, a platelet glycoprotein IIb/IIIa antagonist, in addition to standard heparin and warfarin sodium anticoagulation and low-dose aspirin. She did not